Wockhardt Ltd

NSE: WOCKPHARMA · BSE: 532300 · Pharmaceuticals & Biotechnology · 28 announcements

Share price: ₹2,137.20
Market cap: ₹34,728 Cr
Revenue (annual): ₹3,373 Cr
Net profit (annual): ₹213.0 Cr
P/E (TTM): 84.9×Sector 47.4×
Promoter holding: 49.08%+0.00% QoQ
FII holding: 7.23%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Board Meeting Date 5 Other Announcement 4 Annual General Meeting 4 Financial Results 3 Management Change 2 Legal & Regulatory 2 Earnings Call 2 Business Update 2 Results Update 1 Regulatory Approval 1 Fund Raise 1 Credit Rating 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

4 May 2026 19:04 IST NSE

Management Change

Wockhardt Management Change

Wockhardt Limited announced three senior management appointments. Mr. Om Narayan and Mr. Sunil Soni join as Senior Vice Presidents in Biotech Research and Biotechnology, respectively. Ms. Annapurna Das, formerly of Takeda India, is appointed President for India Business & Emerging Markets (NCE). These leadership additions bring extensive pharmaceutical and biotech expertise to the company.

Read the filing ↗

4 May 2026 18:34 IST BSE

Management Change

Wockhardt Management Change

Wockhardt Limited has designated Ms. Annapurna Das, Mr. Om Narayan, and Mr. Sunil Soni as Senior Management Personnel effective May 4, 2026. These appointments strengthen the company's leadership in India business, emerging markets, biotech research, and biotechnology operations.

Read the filing ↗